An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis

NCT02641730 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Palmoplantar Pustulosis

Interventions

DRUG: Guselkumab
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.